Earlier diagnoses of asymptomatic GBA1 variant carriers would enable inclusion into longitudinal investigations of prodromal PD markers, aiding characterization of the prodrome and the search for validated biomarkers of progression to PD. The gene discussed is GBA1; the disease is Parkinson disease.